{
    "2020-11-08": [
        [
            {
                "time": "",
                "original_text": "冠脉支架集采落地，医疗耗材利空压制释放【东吴医药朱国广团队|1106周报】",
                "features": {
                    "keywords": [
                        "冠脉支架",
                        "集采",
                        "医疗耗材",
                        "利空",
                        "压制释放"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "预告第六弹：上市公司与机构投资者见面会",
                "features": {
                    "keywords": [
                        "上市公司",
                        "机构投资者",
                        "见面会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【中航证券医药】行业周报 | 高值耗材集采落地，降价幅度超出预期",
                "features": {
                    "keywords": [
                        "高值耗材",
                        "集采",
                        "降价",
                        "超出预期"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "频频失手 4300亿高瓴资本投资神话能否继续？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "投资",
                        "神话",
                        "失手"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
                "features": {
                    "keywords": [
                        "估值",
                        "回落",
                        "业绩加速",
                        "CDMO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}